ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,315 | -13.4% | 1,216 | +4.7% | 0.00% | – |
| Q2 2023 | $15,372 | +286.8% | 1,161 | +297.6% | 0.00% | – |
| Q1 2023 | $3,974 | +48.5% | 292 | +113.1% | 0.00% | – |
| Q4 2022 | $2,676 | -10.8% | 137 | -24.7% | 0.00% | – |
| Q3 2022 | $3,000 | – | 182 | +1200.0% | 0.00% | – |
| Q2 2022 | $0 | – | 14 | +180.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 5 | -83.3% | 0.00% | – |
| Q2 2021 | $1,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |